Clinical trial

Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers

NCT01181063

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-08-01

PhasePHASE1

Study timeline

Study start (unknown)2010-08-01Date precision: month

Registry last updated2011-06-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

Budesonide/formoterol 320/9 μg and 400/12 μg inhalersDRUG

Sponsors & collaborators

Orion Corporation, Orion Pharmalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01181063 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.